Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-12

Clinical Trial Update: Chikungunya Virus Vaccine Trial in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a chikungunya virus vaccine in healthy adults completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chikungunya virus vaccine (NIAID Phase 1 trial)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Viral Vaccines, Chikungunya Fever | Phase 1 | Status: COMPLETED | Results posted: 2016-04-12